Applied Dna Scns (APDN) is trading 67% higher at $4.68 today.

Applied Dna Scns has been trading between a 52-week high of $6.97 and a 52-week low of $0.6243. The stock has a market cap of $42 Million.

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ('PCR')-based manufacturing platform that allows for the large-scale production of specific DNA sequences. The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies.

Thinking about buying stock in Applied DNA Sciences, Helius Medical Technologies, Eargo, Ping Identity, or Chembio Diagnostics?
Benzinga 08-03-22

BNGO, NTLA and OPTT are among pre market gainers
Seeking Alpha 08-03-22

A small biotech firm’s stock spiked 425% after giving a positive update on a PCR test for monkeypox
Business Insider Nederlands 08-02-22

Applied DNA Sciences Shares Triples After Monkeypox Diagnostic Test Update
Benzinga 08-02-22

LTRPA, LTRPB Stock Alert: What Is Going on With Liberty TripAdvisor?
InvestorPlace 08-02-22